Hosted on MSN11mon
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaos
Patients will have a harder time getting their Humalog and Insulin Lispro Injections at wholesalers and pharmacies through the beginning of next month, the company said. In the meantime ...
pharmaphorum4d
Civica plans shake-up of insulin sector with low-cost biosimilars
and Eli Lilly's Humalog (insulin lispro) – will be priced at no more than $30 per vial and no more than $55 for a box of five pen cartridges – which Civica says is "a significant discount to ...